RFS
Term · Oncology and biomedicine · MLC-T-ONC-007424
In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that cancer. In a clinical trial, measuring the RFS is one way to see how well a new treatment works. Also called DFS, disease-free survival, and relapse-free survival.
| Identifier | MLC-T-ONC-007424 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | disease-free survival; relapse-free survival |
| Synonyms | DFS |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007424",
"term": "RFS",
"field": "Oncology and biomedicine",
"definition": "In cancer, the length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that cancer. In a clinical trial, measuring the RFS is one way to see how well a new treatment works. Also called DFS, disease-free survival, and relapse-free survival.",
"expansions": [
"disease-free survival",
"relapse-free survival"
],
"synonyms": [
"DFS"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/rfs/"
}
Record 14,438 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.